ArticleBMC surgery2025
Laparoscopic-assisted hydrostatic reduction of pediatric intussusception: a prospective study from a single tertiary center.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAfter failed ultrasound-guided hydrostatic reduction (USGHR), operative options vary. We evaluated a protocolized laparoscopic-assisted hydrostatic reduction (LAHR) pathway as an escalation strategy.
methodsThis prospective study included 242 children with intussusception treated at a single tertiary center between January 2023 and December 2024. All children received standardized USGHR (≤ 3 attempts in one session). Failures proceeded to LAHR under standardized hydrostatic pressure (80–100 cm H₂O); persistent non-reduction or ischemia/lead point prompted mini-laparotomy and resection. Primary outcome was LAHR success; secondary outcomes included early recurrence (≤ 48 h), complications, time to feeds, and length of stay (LOS). Discharge was milestone-based.
resultsOf 242 children, USGHR succeeded in 189 (78.1%); 53 (21.9%) underwent LAHR. LAHR succeeded in 45/53 (84.9%); 8/53 (15.1%) required laparotomy. No intraoperative perforations occurred. Complications after LAHR were low: intraperitoneal infection 1.9%, ileus 3.8%, wound infection 1.9%. Time to enteral feeding was 8.2 ± 1.7 h after uncomplicated LAHR and 47.5 ± 5.8 h with resection. Mean LOS was 1.54 ± 0.36 days after uncomplicated LAHR, 4.25 ± 0.71 days with resection, and 1.95 ± 1.07 days overall. No early (≤ 48 h) recurrences were detected on routine in-hospital surveillance.
conclusionsA pressure-standardized LAHR pathway is a safe, effective escalation after failed USGHR, achieving high reduction success with low morbidity, rapid feeding, short LOS, and no early recurrences. These reproducible methods offer actionable benchmarks for multicenter comparison; confirmation in larger, comparative cohorts with longer follow-up is warranted.
trial registrationThe Pan African Clinical Trial Registry (pactr.samrc.ac.za) database, PACTR202508726005103, Registration date: 14 August 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.